th World Medical Nanotechnology Congress - E27 Nanotechnology 2017... · Global Summit on Medical Nanotechnology is going to ... The report also carries out an in-depth analysis of

www.medicalnanotechnology.conferenceseries.com

Medical Nanotechnology 2017conferenceseries.com

Conference Secretariat2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA

Ph: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499Email: [email protected]

Brochure15th World Medical Nanotechnology

CongressOsaka, Japan October 18-19, 2017



Medical Nanotechnology 2017 welcomes you to attend the 15th World Medical Nanotechnology Congress which is going to be held in Osaka, Japan during October 18-19, 2017.

We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of 15th World Medical Nanotechnology Congress.

Medical Nanotechnology 2017 anticipates more than 500 participants around the globe with thought provoking Keynote lectures, Oral Presentations and Poster Presentations. The attending delegates include Editorial Board Members of related International Journals.

This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

The intending participants can confirm their participation by registering for the conference along with your colleagues.

The main theme of the conference is “Advances of Nanomedicine in diagnosis theranostics”. Avail the delegate early bird offer.

Regards,

Medical Nanotechnology 2017 Operating Committee

• Nanomedicine• Nanoelectronics and Biomedical Devices• DNA Nanotechnology• Nano Pharmaceuticals• Nanomedicine and Drug Delivery• Nanotechnology in Cardiovascular Medicine• Cancer Nanotechnology• Nanotoxicity• Graphene Nanomedicine• Nanotechnology for Health care

• Nanotechnology for Pediatric Medicine• Polymer Nanotechnology• Advanced Nanomaterials• NanoBiotechnology• Nanotechnology and Cosmetics• Biomaterials and Tissues Engineering• Nano Computing• Nanotechnology in Life Sciences & Medicine• Recent developments in Nanotechnology• Environment, Health and Safety Issues

Conference Highlights

Invitation



Welcome Message



Welcome Message


Medical Nanotechnology 2017conferenceseries.comMarket Analysis

Summary of Medical Nanotechnology 2017 Conference:-STUDY BACKGROUNDWhile it appears inevitable that nanotechnology will have a broad and fundamental impact on many sectors of the U.S. economy, various technical, marketing and other hurdles need to be overcome before nanotechnology fulfills this promise. These challenges and differences of opinion regarding commercial applications are reflected in the widely diverging estimates of the U.S. and global nanotechnology markets.

Estimates of the global nanotechnology market in 2010 range from about $15.7 billion (the figure used in this report) to $1 trillion. By 2016, the market may be worth more than $2.4 trillion, according to different analysts. These differences reflect not only different analytical methods and assumptions, but also different definitions of the nanotechnology market (e.g., whether to include decades-old technologies such as carbon black rubber reinforcers and photographic silver, or whether to base the market value on nanotechnology inputs alone, as opposed to the total value of products that incorporate nanotechnology).

Perhaps as a reflection of the difficulty of quantifying the market for nanotechnologies, some analysts downplay the commercial dimensions of the nanotechnology market, and focus instead on the supply side, i.e., the development of new nanoscale technologies and applications. These analysts have made valuable contributions, raising investors’ awareness of and interest in nanotechnologies.

However, by itself, the work of these analysts does not provide sufficient information in order to guide corporate or individual investment decisions. Investors require additional data, such as the size of specific nanotechnology markets, prices, and competition, as well as potential regulation.

STUDY GOALS AND OBJECTIVESThe goal of this report is to provide investors and others with information on the commercial potential of various nanotechnologies and to complement the growing body of technical information. Specific objectives include identifying segments of the nanotechnology market with the greatest commercial potential in the near to mid-term (2010 through 2015), projecting future demand in these segments, and evaluating the challenges that must be overcome for each segment to realize its potential in order to estimate the probability of successful commercialization.

INTENDED AUDIENCE The report is especially intended for entrepreneurs, investors, venture capitalists, and other readers with a need to know where the nanotechnology market is headed in the next 5 years. Other readers who should find the report particularly valuable include nanotechnology marketing executives and government officials associated with the National Nanotechnology Initiative and other state-level programs that promote the development of the nanotechnology industry. The report’s findings and conclusions should also be of interest to the broader nanotechnology community.


Medical Nanotechnology 2017conferenceseries.comWhy Osaka?Global Summit on Medical Nanotechnology is going to be held in Osaka, Japan. Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka has also been known as the “Nation’s Kitchen”. With a population of 2.5 million, Osaka is Japan’s third largest and second most important city. It has been the economic powerhouse of the Kansai region for many centuries. The city’s west side has the main port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky building and the TempozanHarbour Village. The Museum of Oriental Ceramics holds more than 2,000 pieces of ceramics, from China, Korea, Japan and Vietnam, featuring displays of some of their Korean celadon under natural light.

SCOPE OF REPORT The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019.

The report talks about the major growth areas of within the nanomedicine market over the period of forecast. The introduction of new technologies and applications in this sector will propel growth to a significant degree at the global level. Further, the initiatives taken by various governments as well as privately-funded institutions towards promoting the commercialization of new nanomedicine products will boost this market. The report also dwells on the role played by the rising geriatric population base, the prevalence of medical needs that are in need of treatment, as well as the rising incidence of chronic diseases globally.

According to the report, the leading application segment within the nanomedicine market was that of oncology, holding a 38% share of the overall market in 2012, as a vast number of commercially available products prevail in this sector.

The development of nanomedicine-based treatments and products that are able to directly target tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in this market.

Though the largest market segment within the nanomedicine market is that of oncology, the fastest growing segment is the cardiovascular market. According to the Transparency Market Research report, growth in this segment has been fuelled by the presence of a sizeable patient population, and a simultaneous growth in the demand for device and drugs that are based on nanomedicine. These factors are collectively anticipated to further fuel the growth of the cardiovascular segment within the nanomedicine market.

The report also carries out an in-depth analysis of the regional market share based on the applications, revenue, and products. According to the report, the nanomedicine market was largely dominated by North America in 2012. It is expected that this regional market will continue to hold its leading position in the way over the forecast period until 2019.

Though the larger market share will be held by North America, it is anticipated that the fastest growing market, by region, will be Asia-Pacific. The report states that the CAGR recorded by the Asia-Pacific market will be 14.6% between 2013 and 2019.


Medical Nanotechnology 2017conferenceseries.comFurthermore, the analysis of the regional markets also concludes that the Europe region is predicted to show a growth rate that’s relatively higher than that of North America. Factors that are likely to cause this increased growth rate include: an improvement in the regulatory framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be introduced by leading market players.

The report on the global nanomedicine market additionally comprises an overview of the key market players in a section dedicated to company profiles. These key market players include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere Inc., and many more.

Nanomedicine study in various countries:

GLOBAL MARKETThe emergence of nanomedicine and the application of nanomaterials in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario.Some of thedrivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and others.

The global nanomedicine market is categorized into six segments on the basis of application, namely neurology, cardiovascular, anti-inflammatory, anti-infective, oncology and others.

Oncology held majority of the market share in 2012 on account of following factors:• Presence of high number of commercialized nanomedicine products in the market• Improved bioavailability and efficacy of the tumor specific nanomedicine enabling targeted

drug delivery• Rise in nanomedicine drug formulations replacing conventional drug formulations in cancer

treatment

However, the global market for cardiovascular segment is expected to grow at the fastest pace owing to increasing prevalence of cardiovascular diseases demanding drugs with improved efficacy and therapeutic properties. Furthermore, realizing the importance and benefits of nanomedicine, researchers and manufacturers are striving to develop products with improved therapeutic properties in the cardiovascular segment.

The North American nanomedicine market held the majority of global market share in 2012 because of the rapidly growing nanomedicine market in the Asia–Pacific, Latin American and African region, presence of large number of patented nanomedicine products and favorable regulatory framework in the region.In addition, the presence of sophisticated healthcare


Medical Nanotechnology 2017conferenceseries.cominfrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region.China is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.

Overall research in various disciplines:

REPORT HIGHLIGHTSThe global Nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CA GR) of 14.1% between years 2011 and 2016.



International Journals • 500 Open Access Journals• 21 Day rapid review process• 30000 Editorial team, 35000 Reviewers team• 3.5 Million readers and high visibility• More than 100000 • Publication immediately after acceptance• Quality and quick editorial, review processing

Key features • User friendly/feasible website translation of your paper to 50

world’s leading languages • Enhanced feature: Audio version of published paper• Digital articles to share and explore• Sharing option: Social networking enabled• Authors, reviewers and editors are provided with scientific

credits

Conference Series LLC Conferences • 300 Conferences all over the World every year• Well organized scientific program • Renowned speakers and scientists across the globe• Poster presentations and world class exhibits• Panel discussions and interactive sessions• B2B meetings• Perfect platform for Global Networking

Key features • Presentation by renowned speakers from all over the world• Poster presentations and world class exhibits• Interactive Sessions• Platform for global networking• Connecting scientific community

Special Issues All accepted abstracts will be published in respective International Journals

Each abstract will be provided with digital Object Identifier by

About Us



Shaker MousaExecutive Vice President and Chairman

Pharmaceutical Research InstituteUSA

Bharat BhushanDirector

The Ohio State UniversityUSA

Mary Mehrnoosh Eshaghian WilnerProfessor

University of Southern CaliforniaUSA

Esmaiel JabbariProfessor

University of South CarolinaUSA

Hicham FenniriProfessor

The Northeastern SupramolecularNanomaterials Lab

USA

Hussein Osman AmmarChairman

Faculty of PharmacyFuture University in Egypt

Egypt

Der-Jang LIAWChair Professor

National Taiwan University of Science and Technology

Taiwan

Aharon GedankenSenior Prof. (Emeritus)

Bar-Ilan Institute of Nanotechnology and Advanced

Materials (BINA), Israel

Organizing Committee Members



15th World Medical Nanotechnology Congress 2017 is the premier event that brings together a unique and international mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, expertise and research innovations to build a world class 15th World Medical Nanotechnology Congress conference

The event focuses on aspects such as breeding, molecular marker development, crop/ trait improvement, disease resistance, epigenetics, evolution studies and pathology as well understanding tools to overcome barrier and enable successful data analysis and management. Presentations concentrate not only particular to 15th World Medical Nanotechnology Congress but also crop and forestry research ranging from wheat, barley, maize and rice to potato, tomato, arabidopsis, biofuels and various fruits.

Medical Nanotechnology 2017• Opportunity to attend the presentations delivered by eminent scientists from all over the world• Selected contributions will be published in following International Journals

• Journal of Nanomedicine & Nanotechnology

• Journal of Nanomaterials & Molecular Nanotechnology

• Journal of Nanomedicine & Biotherapeutic Discovery

• Participation in sessions on specific topics on which the conference is expected to achieve progress • Global networking: In transferring and exchanging Ideas• Share your excitement in promoting Health care, Clinical R & D

• Conference brings together Scientific Researchers, Business Entrepreneurs and Pharma, Healthcare, Industry Developers

Important DatesAbstract submission deadline: May 29, 2017Early bird registration: May 31, 2017On spot registration: October 18, 2017

VenueHyatt Regency Osaka 1-13-11 Nanko-Kita, Suminoe-Ku Osaka, Japan 559-0034.

Medical Nanotechnology 2017



Osaka is the second largest metropolitan area in Japan and serves a major economichub. Historically a merchant city, Osaka has also been known as the “Nation’s Kitchen”. Witha population of 2.5 million, Osaka is Japan’s third largest and second most important city. It hasbeen the economic powerhouse of the Kansai region for many centuries. The city’s west side hasthe main port as well as a tourist destination with attractions such as Kyocera Dome, UniversalStudios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky building and the TempozanHarbour Village.

Osaka is known for its food, both in Japan and abroad. Author Michael Boothand food critic François Simon of Le Figaro have both suggested that Osaka is the food capitalof the world. Osaka’s culinary prevalence is the result of a location that has provided access tohigh quality ingredients, a high population of merchants, and close proximity to the ocean andwaterway trade. In recent years, Osaka has started to garner more attention from foreigners withthe increased popularity of cooking and dining in popular culture.

About Osaka

Documents

th World Medical Nanotechnology Congress - E27 Nanotechnology 2017... · Global Summit on Medical Nanotechnology is going to ... The report also carries out an in-depth analysis of